 | • レポートコード：MRC2-11QY10831 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は肛門癌・結腸直腸癌のグローバル市場について調査・分析したレポートです。種類別（手術、放射線療法、結腸直腸癌化学療法、標的療法、免疫療法）市場規模、用途別（病院、外来手術センター、がん研究センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別肛門癌・結腸直腸癌の競争状況、市場シェア ・世界の肛門癌・結腸直腸癌市場：種類別市場規模 2015年-2020年（手術、放射線療法、結腸直腸癌化学療法、標的療法、免疫療法） ・世界の肛門癌・結腸直腸癌市場：種類別市場規模予測 2021年-2026年（手術、放射線療法、結腸直腸癌化学療法、標的療法、免疫療法） ・世界の肛門癌・結腸直腸癌市場：用途別市場規模 2015年-2020年（病院、外来手術センター、がん研究センター） ・世界の肛門癌・結腸直腸癌市場：用途別市場規模予測 2021年-2026年（病院、外来手術センター、がん研究センター） ・北米の肛門癌・結腸直腸癌市場分析：米国、カナダ ・ヨーロッパの肛門癌・結腸直腸癌市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの肛門癌・結腸直腸癌市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の肛門癌・結腸直腸癌市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの肛門癌・結腸直腸癌市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Diagnostics、Advaxis、Abbott、Amgen、Atara Biotherapeutics、Bayer、Metabiomics、Beckman Coulter、BeiGene、Boehringer Ingelheim、Clinical Genomics、EDP Biotech、Eli Lilly、Epigenomics、Exact Sciences、Genomictree、Immunovaccine、ISA Pharmaceuticals、Merck ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Colorectal cancer is a malignant tumor that starts in the cells of the colon or the rectum while it takes place in anus in case of anal cancer.
Rising prevalence of anal and colorectal cancer due to poor lifestyles such as obesity and tobacco consumption has been the major factor driving the market growth.
Market Analysis and Insights: Global Anal and Colorectal Cancer Market
The global Anal and Colorectal Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Anal and Colorectal Cancer Scope and Market Size
Anal and Colorectal Cancer market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anal and Colorectal Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Diagnostics
Advaxis
Abbott
Amgen
Atara Biotherapeutics
Bayer
Metabiomics
Beckman Coulter
BeiGene
Boehringer Ingelheim
Clinical Genomics
EDP Biotech
Eli Lilly
Epigenomics
Exact Sciences
Genomictree
Immunovaccine
ISA Pharmaceuticals
Merck
Market segment by Type, the product can be split into
Surgery
Radiation therapy
Colorectal cancer chemotherapy
Targeted therapy
Immunotherapy
Market segment by Application, split into
Hospitals
Ambulatory surgery centers
Cancer research centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Anal and Colorectal Cancer Revenue
1.4 Market by Type
1.4.1 Global Anal and Colorectal Cancer Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Surgery
1.4.3 Radiation therapy
1.4.4 Colorectal cancer chemotherapy
1.4.5 Targeted therapy
1.4.6 Immunotherapy
1.5 Market by Application
1.5.1 Global Anal and Colorectal Cancer Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory surgery centers
1.5.4 Cancer research centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Anal and Colorectal Cancer Market Perspective (2015-2026)
2.2 Global Anal and Colorectal Cancer Growth Trends by Regions
2.2.1 Anal and Colorectal Cancer Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Anal and Colorectal Cancer Historic Market Share by Regions (2015-2020)
2.2.3 Anal and Colorectal Cancer Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Anal and Colorectal Cancer Market Growth Strategy
2.3.6 Primary Interviews with Key Anal and Colorectal Cancer Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Anal and Colorectal Cancer Players by Market Size
3.1.1 Global Top Anal and Colorectal Cancer Players by Revenue (2015-2020)
3.1.2 Global Anal and Colorectal Cancer Revenue Market Share by Players (2015-2020)
3.1.3 Global Anal and Colorectal Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Anal and Colorectal Cancer Market Concentration Ratio
3.2.1 Global Anal and Colorectal Cancer Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Anal and Colorectal Cancer Revenue in 2019
3.3 Anal and Colorectal Cancer Key Players Head office and Area Served
3.4 Key Players Anal and Colorectal Cancer Product Solution and Service
3.5 Date of Enter into Anal and Colorectal Cancer Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Anal and Colorectal Cancer Historic Market Size by Type (2015-2020)
4.2 Global Anal and Colorectal Cancer Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Anal and Colorectal Cancer Market Size by Application (2015-2020)
5.2 Global Anal and Colorectal Cancer Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Anal and Colorectal Cancer Market Size (2015-2020)
6.2 Anal and Colorectal Cancer Key Players in North America (2019-2020)
6.3 North America Anal and Colorectal Cancer Market Size by Type (2015-2020)
6.4 North America Anal and Colorectal Cancer Market Size by Application (2015-2020)
7 Europe
7.1 Europe Anal and Colorectal Cancer Market Size (2015-2020)
7.2 Anal and Colorectal Cancer Key Players in Europe (2019-2020)
7.3 Europe Anal and Colorectal Cancer Market Size by Type (2015-2020)
7.4 Europe Anal and Colorectal Cancer Market Size by Application (2015-2020)
8 China
8.1 China Anal and Colorectal Cancer Market Size (2015-2020)
8.2 Anal and Colorectal Cancer Key Players in China (2019-2020)
8.3 China Anal and Colorectal Cancer Market Size by Type (2015-2020)
8.4 China Anal and Colorectal Cancer Market Size by Application (2015-2020)
9 Japan
9.1 Japan Anal and Colorectal Cancer Market Size (2015-2020)
9.2 Anal and Colorectal Cancer Key Players in Japan (2019-2020)
9.3 Japan Anal and Colorectal Cancer Market Size by Type (2015-2020)
9.4 Japan Anal and Colorectal Cancer Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Anal and Colorectal Cancer Market Size (2015-2020)
10.2 Anal and Colorectal Cancer Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Anal and Colorectal Cancer Market Size by Type (2015-2020)
10.4 Southeast Asia Anal and Colorectal Cancer Market Size by Application (2015-2020)
11 India
11.1 India Anal and Colorectal Cancer Market Size (2015-2020)
11.2 Anal and Colorectal Cancer Key Players in India (2019-2020)
11.3 India Anal and Colorectal Cancer Market Size by Type (2015-2020)
11.4 India Anal and Colorectal Cancer Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Anal and Colorectal Cancer Market Size (2015-2020)
12.2 Anal and Colorectal Cancer Key Players in Central & South America (2019-2020)
12.3 Central & South America Anal and Colorectal Cancer Market Size by Type (2015-2020)
12.4 Central & South America Anal and Colorectal Cancer Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Diagnostics
13.1.1 Abbott Diagnostics Company Details
13.1.2 Abbott Diagnostics Business Overview
13.1.3 Abbott Diagnostics Anal and Colorectal Cancer Introduction
13.1.4 Abbott Diagnostics Revenue in Anal and Colorectal Cancer Business (2015-2020))
13.1.5 Abbott Diagnostics Recent Development
13.2 Advaxis
13.2.1 Advaxis Company Details
13.2.2 Advaxis Business Overview
13.2.3 Advaxis Anal and Colorectal Cancer Introduction
13.2.4 Advaxis Revenue in Anal and Colorectal Cancer Business (2015-2020)
13.2.5 Advaxis Recent Development
13.3 Abbott
13.3.1 Abbott Company Details
13.3.2 Abbott Business Overview
13.3.3 Abbott Anal and Colorectal Cancer Introduction
13.3.4 Abbott Revenue in Anal and Colorectal Cancer Business (2015-2020)
13.3.5 Abbott Recent Development
13.4 Amgen
13.4.1 Amgen Company Details
13.4.2 Amgen Business Overview
13.4.3 Amgen Anal and Colorectal Cancer Introduction
13.4.4 Amgen Revenue in Anal and Colorectal Cancer Business (2015-2020)
13.4.5 Amgen Recent Development
13.5 Atara Biotherapeutics
13.5.1 Atara Biotherapeutics Company Details
13.5.2 Atara Biotherapeutics Business Overview
13.5.3 Atara Biotherapeutics Anal and Colorectal Cancer Introduction
13.5.4 Atara Biotherapeutics Revenue in Anal and Colorectal Cancer Business (2015-2020)
13.5.5 Atara Biotherapeutics Recent Development
13.6 Bayer
13.6.1 Bayer Company Details
13.6.2 Bayer Business Overview
13.6.3 Bayer Anal and Colorectal Cancer Introduction
13.6.4 Bayer Revenue in Anal and Colorectal Cancer Business (2015-2020)
13.6.5 Bayer Recent Development
13.7 Metabiomics
13.7.1 Metabiomics Company Details
13.7.2 Metabiomics Business Overview
13.7.3 Metabiomics Anal and Colorectal Cancer Introduction
13.7.4 Metabiomics Revenue in Anal and Colorectal Cancer Business (2015-2020)
13.7.5 Metabiomics Recent Development
13.8 Beckman Coulter
13.8.1 Beckman Coulter Company Details
13.8.2 Beckman Coulter Business Overview
13.8.3 Beckman Coulter Anal and Colorectal Cancer Introduction
13.8.4 Beckman Coulter Revenue in Anal and Colorectal Cancer Business (2015-2020)
13.8.5 Beckman Coulter Recent Development
13.9 BeiGene
13.9.1 BeiGene Company Details
13.9.2 BeiGene Business Overview
13.9.3 BeiGene Anal and Colorectal Cancer Introduction
13.9.4 BeiGene Revenue in Anal and Colorectal Cancer Business (2015-2020)
13.9.5 BeiGene Recent Development
13.10 Boehringer Ingelheim
13.10.1 Boehringer Ingelheim Company Details
13.10.2 Boehringer Ingelheim Business Overview
13.10.3 Boehringer Ingelheim Anal and Colorectal Cancer Introduction
13.10.4 Boehringer Ingelheim Revenue in Anal and Colorectal Cancer Business (2015-2020)
13.10.5 Boehringer Ingelheim Recent Development
13.11 Clinical Genomics
10.11.1 Clinical Genomics Company Details
10.11.2 Clinical Genomics Business Overview
10.11.3 Clinical Genomics Anal and Colorectal Cancer Introduction
10.11.4 Clinical Genomics Revenue in Anal and Colorectal Cancer Business (2015-2020)
10.11.5 Clinical Genomics Recent Development
13.12 EDP Biotech
10.12.1 EDP Biotech Company Details
10.12.2 EDP Biotech Business Overview
10.12.3 EDP Biotech Anal and Colorectal Cancer Introduction
10.12.4 EDP Biotech Revenue in Anal and Colorectal Cancer Business (2015-2020)
10.12.5 EDP Biotech Recent Development
13.13 Eli Lilly
10.13.1 Eli Lilly Company Details
10.13.2 Eli Lilly Business Overview
10.13.3 Eli Lilly Anal and Colorectal Cancer Introduction
10.13.4 Eli Lilly Revenue in Anal and Colorectal Cancer Business (2015-2020)
10.13.5 Eli Lilly Recent Development
13.14 Epigenomics
10.14.1 Epigenomics Company Details
10.14.2 Epigenomics Business Overview
10.14.3 Epigenomics Anal and Colorectal Cancer Introduction
10.14.4 Epigenomics Revenue in Anal and Colorectal Cancer Business (2015-2020)
10.14.5 Epigenomics Recent Development
13.15 Exact Sciences
10.15.1 Exact Sciences Company Details
10.15.2 Exact Sciences Business Overview
10.15.3 Exact Sciences Anal and Colorectal Cancer Introduction
10.15.4 Exact Sciences Revenue in Anal and Colorectal Cancer Business (2015-2020)
10.15.5 Exact Sciences Recent Development
13.16 Genomictree
10.16.1 Genomictree Company Details
10.16.2 Genomictree Business Overview
10.16.3 Genomictree Anal and Colorectal Cancer Introduction
10.16.4 Genomictree Revenue in Anal and Colorectal Cancer Business (2015-2020)
10.16.5 Genomictree Recent Development
13.17 Immunovaccine
10.17.1 Immunovaccine Company Details
10.17.2 Immunovaccine Business Overview
10.17.3 Immunovaccine Anal and Colorectal Cancer Introduction
10.17.4 Immunovaccine Revenue in Anal and Colorectal Cancer Business (2015-2020)
10.17.5 Immunovaccine Recent Development
13.18 ISA Pharmaceuticals
10.18.1 ISA Pharmaceuticals Company Details
10.18.2 ISA Pharmaceuticals Business Overview
10.18.3 ISA Pharmaceuticals Anal and Colorectal Cancer Introduction
10.18.4 ISA Pharmaceuticals Revenue in Anal and Colorectal Cancer Business (2015-2020)
10.18.5 ISA Pharmaceuticals Recent Development
13.19 Merck
10.19.1 Merck Company Details
10.19.2 Merck Business Overview
10.19.3 Merck Anal and Colorectal Cancer Introduction
10.19.4 Merck Revenue in Anal and Colorectal Cancer Business (2015-2020)
10.19.5 Merck Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Anal and Colorectal Cancer Key Market Segments
Table 2. Key Players Covered: Ranking by Anal and Colorectal Cancer Revenue
Table 3. Ranking of Global Top Anal and Colorectal Cancer Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Anal and Colorectal Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Surgery
Table 6. Key Players of Radiation therapy
Table 7. Key Players of Colorectal cancer chemotherapy
Table 8. Key Players of Targeted therapy
Table 9. Key Players of Immunotherapy
Table 10. Global Anal and Colorectal Cancer Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Anal and Colorectal Cancer Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Anal and Colorectal Cancer Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Anal and Colorectal Cancer Market Share by Regions (2015-2020)
Table 14. Global Anal and Colorectal Cancer Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Anal and Colorectal Cancer Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Anal and Colorectal Cancer Market Growth Strategy
Table 20. Main Points Interviewed from Key Anal and Colorectal Cancer Players
Table 21. Global Anal and Colorectal Cancer Revenue by Players (2015-2020) (Million US$)
Table 22. Global Anal and Colorectal Cancer Market Share by Players (2015-2020)
Table 23. Global Top Anal and Colorectal Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anal and Colorectal Cancer as of 2019)
Table 24. Global Anal and Colorectal Cancer by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Anal and Colorectal Cancer Product Solution and Service
Table 27. Date of Enter into Anal and Colorectal Cancer Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Anal and Colorectal Cancer Market Size by Type (2015-2020) (Million US$)
Table 30. Global Anal and Colorectal Cancer Market Size Share by Type (2015-2020)
Table 31. Global Anal and Colorectal Cancer Revenue Market Share by Type (2021-2026)
Table 32. Global Anal and Colorectal Cancer Market Size Share by Application (2015-2020)
Table 33. Global Anal and Colorectal Cancer Market Size by Application (2015-2020) (Million US$)
Table 34. Global Anal and Colorectal Cancer Market Size Share by Application (2021-2026)
Table 35. North America Key Players Anal and Colorectal Cancer Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Anal and Colorectal Cancer Market Share (2019-2020)
Table 37. North America Anal and Colorectal Cancer Market Size by Type (2015-2020) (Million US$)
Table 38. North America Anal and Colorectal Cancer Market Share by Type (2015-2020)
Table 39. North America Anal and Colorectal Cancer Market Size by Application (2015-2020) (Million US$)
Table 40. North America Anal and Colorectal Cancer Market Share by Application (2015-2020)
Table 41. Europe Key Players Anal and Colorectal Cancer Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Anal and Colorectal Cancer Market Share (2019-2020)
Table 43. Europe Anal and Colorectal Cancer Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Anal and Colorectal Cancer Market Share by Type (2015-2020)
Table 45. Europe Anal and Colorectal Cancer Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Anal and Colorectal Cancer Market Share by Application (2015-2020)
Table 47. China Key Players Anal and Colorectal Cancer Revenue (2019-2020) (Million US$)
Table 48. China Key Players Anal and Colorectal Cancer Market Share (2019-2020)
Table 49. China Anal and Colorectal Cancer Market Size by Type (2015-2020) (Million US$)
Table 50. China Anal and Colorectal Cancer Market Share by Type (2015-2020)
Table 51. China Anal and Colorectal Cancer Market Size by Application (2015-2020) (Million US$)
Table 52. China Anal and Colorectal Cancer Market Share by Application (2015-2020)
Table 53. Japan Key Players Anal and Colorectal Cancer Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Anal and Colorectal Cancer Market Share (2019-2020)
Table 55. Japan Anal and Colorectal Cancer Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Anal and Colorectal Cancer Market Share by Type (2015-2020)
Table 57. Japan Anal and Colorectal Cancer Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Anal and Colorectal Cancer Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Anal and Colorectal Cancer Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Anal and Colorectal Cancer Market Share (2019-2020)
Table 61. Southeast Asia Anal and Colorectal Cancer Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Anal and Colorectal Cancer Market Share by Type (2015-2020)
Table 63. Southeast Asia Anal and Colorectal Cancer Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Anal and Colorectal Cancer Market Share by Application (2015-2020)
Table 65. India Key Players Anal and Colorectal Cancer Revenue (2019-2020) (Million US$)
Table 66. India Key Players Anal and Colorectal Cancer Market Share (2019-2020)
Table 67. India Anal and Colorectal Cancer Market Size by Type (2015-2020) (Million US$)
Table 68. India Anal and Colorectal Cancer Market Share by Type (2015-2020)
Table 69. India Anal and Colorectal Cancer Market Size by Application (2015-2020) (Million US$)
Table 70. India Anal and Colorectal Cancer Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Anal and Colorectal Cancer Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Anal and Colorectal Cancer Market Share (2019-2020)
Table 73. Central & South America Anal and Colorectal Cancer Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Anal and Colorectal Cancer Market Share by Type (2015-2020)
Table 75. Central & South America Anal and Colorectal Cancer Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Anal and Colorectal Cancer Market Share by Application (2015-2020)
Table 77. Abbott Diagnostics Company Details
Table 78. Abbott Diagnostics Business Overview
Table 79. Abbott Diagnostics Product
Table 80. Abbott Diagnostics Revenue in Anal and Colorectal Cancer Business (2015-2020) (Million US$)
Table 81. Abbott Diagnostics Recent Development
Table 82. Advaxis Company Details
Table 83. Advaxis Business Overview
Table 84. Advaxis Product
Table 85. Advaxis Revenue in Anal and Colorectal Cancer Business (2015-2020) (Million US$)
Table 86. Advaxis Recent Development
Table 87. Abbott Company Details
Table 88. Abbott Business Overview
Table 89. Abbott Product
Table 90. Abbott Revenue in Anal and Colorectal Cancer Business (2015-2020) (Million US$)
Table 91. Abbott Recent Development
Table 92. Amgen Company Details
Table 93. Amgen Business Overview
Table 94. Amgen Product
Table 95. Amgen Revenue in Anal and Colorectal Cancer Business (2015-2020) (Million US$)
Table 96. Amgen Recent Development
Table 97. Atara Biotherapeutics Company Details
Table 98. Atara Biotherapeutics Business Overview
Table 99. Atara Biotherapeutics Product
Table 100. Atara Biotherapeutics Revenue in Anal and Colorectal Cancer Business (2015-2020) (Million US$)
Table 101. Atara Biotherapeutics Recent Development
Table 102. Bayer Company Details
Table 103. Bayer Business Overview
Table 104. Bayer Product
Table 105. Bayer Revenue in Anal and Colorectal Cancer Business (2015-2020) (Million US$)
Table 106. Bayer Recent Development
Table 107. Metabiomics Company Details
Table 108. Metabiomics Business Overview
Table 109. Metabiomics Product
Table 110. Metabiomics Revenue in Anal and Colorectal Cancer Business (2015-2020) (Million US$)
Table 111. Metabiomics Recent Development
Table 112. Beckman Coulter Business Overview
Table 113. Beckman Coulter Product
Table 114. Beckman Coulter Company Details
Table 115. Beckman Coulter Revenue in Anal and Colorectal Cancer Business (2015-2020) (Million US$)
Table 116. Beckman Coulter Recent Development
Table 117. BeiGene Company Details
Table 118. BeiGene Business Overview
Table 119. BeiGene Product
Table 120. BeiGene Revenue in Anal and Colorectal Cancer Business (2015-2020) (Million US$)
Table 121. BeiGene Recent Development
Table 122. Boehringer Ingelheim Company Details
Table 123. Boehringer Ingelheim Business Overview
Table 124. Boehringer Ingelheim Product
Table 125. Boehringer Ingelheim Revenue in Anal and Colorectal Cancer Business (2015-2020) (Million US$)
Table 126. Boehringer Ingelheim Recent Development
Table 127. Clinical Genomics Company Details
Table 128. Clinical Genomics Business Overview
Table 129. Clinical Genomics Product
Table 130. Clinical Genomics Revenue in Anal and Colorectal Cancer Business (2015-2020) (Million US$)
Table 131. Clinical Genomics Recent Development
Table 132. EDP Biotech Company Details
Table 133. EDP Biotech Business Overview
Table 134. EDP Biotech Product
Table 135. EDP Biotech Revenue in Anal and Colorectal Cancer Business (2015-2020) (Million US$)
Table 136. EDP Biotech Recent Development
Table 137. Eli Lilly Company Details
Table 138. Eli Lilly Business Overview
Table 139. Eli Lilly Product
Table 140. Eli Lilly Revenue in Anal and Colorectal Cancer Business (2015-2020) (Million US$)
Table 141. Eli Lilly Recent Development
Table 142. Epigenomics Company Details
Table 143. Epigenomics Business Overview
Table 144. Epigenomics Product
Table 145. Epigenomics Revenue in Anal and Colorectal Cancer Business (2015-2020) (Million US$)
Table 146. Epigenomics Recent Development
Table 147. Exact Sciences Company Details
Table 148. Exact Sciences Business Overview
Table 149. Exact Sciences Product
Table 150. Exact Sciences Revenue in Anal and Colorectal Cancer Business (2015-2020) (Million US$)
Table 151. Exact Sciences Recent Development
Table 152. Genomictree Company Details
Table 153. Genomictree Business Overview
Table 154. Genomictree Product
Table 155. Genomictree Revenue in Anal and Colorectal Cancer Business (2015-2020) (Million US$)
Table 156. Genomictree Recent Development
Table 157. Immunovaccine Company Details
Table 158. Immunovaccine Business Overview
Table 159. Immunovaccine Product
Table 160. Immunovaccine Revenue in Anal and Colorectal Cancer Business (2015-2020) (Million US$)
Table 161. Immunovaccine Recent Development
Table 162. ISA Pharmaceuticals Company Details
Table 163. ISA Pharmaceuticals Business Overview
Table 164. ISA Pharmaceuticals Product
Table 165. ISA Pharmaceuticals Revenue in Anal and Colorectal Cancer Business (2015-2020) (Million US$)
Table 166. ISA Pharmaceuticals Recent Development
Table 167. Merck Company Details
Table 168. Merck Business Overview
Table 169. Merck Product
Table 170. Merck Revenue in Anal and Colorectal Cancer Business (2015-2020) (Million US$)
Table 171. Merck Recent Development
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anal and Colorectal Cancer Market Share by Type: 2020 VS 2026
Figure 2. Surgery Features
Figure 3. Radiation therapy Features
Figure 4. Colorectal cancer chemotherapy Features
Figure 5. Targeted therapy Features
Figure 6. Immunotherapy Features
Figure 7. Global Anal and Colorectal Cancer Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Ambulatory surgery centers Case Studies
Figure 10. Cancer research centers Case Studies
Figure 11. Anal and Colorectal Cancer Report Years Considered
Figure 12. Global Anal and Colorectal Cancer Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Anal and Colorectal Cancer Market Share by Regions: 2020 VS 2026
Figure 14. Global Anal and Colorectal Cancer Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Anal and Colorectal Cancer Market Share by Players in 2019
Figure 17. Global Top Anal and Colorectal Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anal and Colorectal Cancer as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Anal and Colorectal Cancer Revenue in 2019
Figure 19. North America Anal and Colorectal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Anal and Colorectal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Anal and Colorectal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Anal and Colorectal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Anal and Colorectal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Anal and Colorectal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Anal and Colorectal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
転移性大腸癌手術の世界市場（～2026年） Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body part…- 大腸がんの世界市場（～2026年） Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine). The major symptoms associated with colorectal cancer include diarrhea, constipation, blood in feces, pain in abdomen, loss of appetite, loss of …
- 大腸がん診断・治療の世界市場（～2026年） Colorectal cancer is the development of cancer from the colonor rectum. The main market drivers are increasing cancer prevention initiatives, technological advancements in radiology and chemotherapy, and increasing incidence and prevalence of colorectal cancer. Market Analysis and Insights: Global C…
- 大腸がん診断の世界市場（～2026年） Fecal occult blood tests dominated the industry in 2016 owing to cost effectiveness and non-invasiveness as compared to colonoscopy and sigmoidoscopy. Immuno-FOB agglutination and Immuno-FOB ELISA tests are major revenue generating segments of fecal occult blood tests segment. Growing awareness alon…
- 膵臓がん治療の世界市場（～2026年） Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity …